Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Timing of stoma reversal could cut hospital stays

NCT ID NCT07754227

Disease control Sponsor: Dr. Waseem Ullah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This trial compares two timings for closing a temporary ileostomy after bowel surgery: early (within 8 weeks) versus delayed (after 8 weeks). The goal is to see which approach leads to a shorter post-operative hospital stay. Adults aged 18-65 with a temporary ileostomy scheduled for elective closure are eligible. The findings may help determine the best time for reversal, potentially improving recovery and reducing healthcare use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Surgical reversal of a temporary ileostomy, performed either early (within 8 weeks) or delayed (after 8 weeks) after the initial bowel surgery.
What this could lead to
If early closure proves better, it could shorten hospital stays, reduce stoma-related complications, and improve quality of life for people with temporary ileostomies.
What could go wrong
This is a small trial, and results may not apply to everyone. Early closure might carry higher surgical risks, and the optimal timing could vary by patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

73 people

The number who actually took part.

Started

Jan 2026

Finished

Jul 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Adults aged 18-65 years. * Male or female participants. * Patients with a temporary ileostomy following bowel surgery. * Patients scheduled for elective ileostomy closure. * Participants willing to provide written informed consent. Exclusion Criteria * Abdominal wall dehiscence. * Tubercular perforation. * Peritoneal contamination. * Patients medically unfit for surgery. * Refusal to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

intestinal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal diseases Ileostomy Intestinal diseases

Contacts and locations

Locations

  • Lady Reading Hospital

    Peshawar, 25000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.